Stryker Corp (SYK):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Stryker Corp (SYK) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7199
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:170
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Stryker Corp (Stryker) is a medical technology company that manufactures an array of orthopaedic, medical and surgical, and neurotechnology and spine products and allied services. Its major products include orthopaedic implants; surgical equipment and surgical navigation systems; patient handling, emergency medical equipment and intensive care disposable products; endoscopic and communications systems; neurosurgical, neurovascular and spinal devices; and medical devices used in a variety of conditions. Stryker offers its products to doctors, hospitals and other healthcare facilities. It has R&D facilities in various countries. The company sells its products through subsidiaries, branches, third-party dealers and distributors in the Americas, Europe, Asia-Pacific, the Middle East and Africa. Stryker is headquartered in Kalamazoo, Michigan, the US.

Stryker Corp (SYK) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Stryker Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Stryker Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Stryker Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Stryker Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 11
Stryker Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Stryker Corp, Medical Equipment, Deal Details 16
Asset Purchase 16
Entellus Medical Acquires XeroGel Assets from CogENT Therapeutics for USD11 Million 16
Stryker Acquires Vertebral Augmentation Solutions Business from Becton, Dickinson 17
Stryker Acquires Minimally-Invasive Spine Surgery Portfolio from SafeWire 18
Stryker Acquires Neuro Portfolio Assets of Synergetics 19
Stryker Acquires Assets of CHG Hospital Beds 20
Stryker Acquires ENT Surgery Business Unit from Polyganics 21
Novadaq to Acquire Rights to SPY Elite System from LifeCell 22
Patient Safety Technologies To Acquire Patents From ClearCount Medical Solutions 23
Mako Surgical Completes Acquisition Of Orthopedic Assets Of Pipeline Biomedical 24
Novadaq Technologies Acquires Surgical Marker Technology From TauTona 25
Novadaq Technologies Acquires Surgical Imaging Technology Assets From Digirad For USD3 Million 26
Stryker Acquires Spinal Implant Technologies From VertiFlex 28
Venture Financing 29
Spirox Raises USD18.5 Million in Series B Financing 29
Stanmore Implants Raises US$12.3 Million In Venture Financing Round 30
Nasoform Raises US$5.3 Million In Venture Financing 31
Private Equity 32
Spirox Raises USD45 Million in Series C Financing 32
Madison Dearborn Partners Completes Acquisition Of Sage Products, Maker Of Disposable Healthcare Products 34
Bain Capital Completes Acquisition Of Physio-Control From Medtronic For US$487 Million 36
Partnerships 38
LaunchPad Medical Enters into Licensing Agreement with Stryker 38
Stryker Enters into Partnership with Ziehm Imaging 39
Synaptive Medical Enters into Partnership with Stryker 40
3D Systems Enters into Distribution Agreement with Stryker 41
Stryker and AlloSource Enter into Distribution Partnership 42
EOS imaging Enters into Co-Promotion Agreement with Stryker 43
Entellus Medical Enters into Co-Marketing Agreement with Xoran Technologies 44
Ziehm Imaging Enters into Co-Marketing Agreement with Stryker 45
Novadaq Technologies Enters into Co-Marketing Agreement with Arthrex 46
Entellus Medical Expands Distribution Agreement with Fiagon 47
Physio-Control Enters into Distribution Agreement with Aircraft Medical 48
Osiris Therapeutics Enters into Agreement with Stryker for Viable Bone Matrix 49
Novadaq Technologies Enters into Distribution Agreement with LifeNet Health for DermACELL Tissue Products 50
Novadaq Enters into Distribution Agreement with Kirloskar 51
Stryker Enters Into Agreement With NeuroLogica For BodyTom CT Scanner 52
Novadaq Enters Into Distribution Agreement With Swissray Asia 53
IMRIS Enters Into Technology Integration Agreement With Stryker 54
Entellus Medical Enters Into Distribution Agreement With CogENT Therapeutics For XeroGel 55
Stryker Extends Co-Marketing Agreement With OrthoSensor 56
NeuroLogica Enters Into Co-Development Agreement With Stryker 57
Novadaq Technologies Enters Into Distribution Agreement With MAQUET Cardiovascular 58
Ember Therapeutics Receives BMP-7 and OP-1 Portfolio from Stryker 59
Equity Offering 60
Entellus Medical Plans to Raise up to USD172.3 Million in Public Offering of Shares 60
Entellus Medical Raises USD50 Million in Private Placement of Shares 61
Entellus Medical Raises USD60 Million in Public Offering of Shares 62
Entellus Medical Raises USD90 Million in IPO 64
Novadaq Technologies Completes Public Offering Of Shares For US$104.7 Million 66
Novadaq Completes Public Offering Of Common Stock For US$58 Million 68
Mako Surgical Completes Public Offering Of Common Stock For US$46 Million 70
Patient Safety Technologies Completes Private Placement Of Shares For US$3.5 Million 71
Novadaq Technologies Completes Public Offering Of Common Shares For US$40 Million 72
Debt Offering 74
Stryker Raises USD600 Million in Public Offering of 3.65% Notes Due 2028 74
Stryker Prices Public Offering of 1.800% Notes Due 2019 for USD500 Million 76
Stryker Raises USD1 Billion in Public Offering of 3.5% Notes Due 2026 77
Stryker Raises USD750 Million in Public Offering of 2% Notes Due 2019 79
Stryker Raises USD750 Million in Public Offering of 2.625% Notes Due 2021 81
Stryker Raises USD1 Billion in Public Offering of 4.625% Notes Due 2046 83
Stryker Raises USD750 Million in Public Offering of 3.375% Notes Due 2025 85
Physio-Control Plans to Raise USD150 Million in Public Offering of Debt 87
Stryker Completes Public Offering Of Notes Due 2024 For US$600 Million 88
Stryker Completes Public Offering Of Notes Due 2044 For US$400 Million 90
Stryker Completes Public Offering Of Notes Due 2018 For US$600 Million 92
Stryker Completes Public Offering Of Notes Due 2043 For US$400 Million 94
Acquisition 96
Stryker Acquires HyperBranch Medical 96
Stryker to Acquire Invuity for USD190 Million 98
Stryker to Acquire K2M Group 100
Stryker to Acquire SafeAir 102
Stryker Acquires Entellus Medical for USD662 Million 103
Stryker to Acquire Vexim 105
Stryker Acquires Novadaq Technologies for USD701 Million 107
Entellus Medical Acquires Spirox from KKR Fund for USD81 Million 109
Stryker to Acquire Instratek 110
Stryker Acquires Stanmore Implants from SIW Holdings for USD52 Million 111
Stryker Acquires Physio-Control for USD1.299 Billion 112
Stryker Acquires Sage Products from Madison Dearborn Partners for USD2.9 Billion 114
Physio-Control to Acquire HeartSine Technologies 116
Stryker Acquires Muka Metal 117
Stryker Completes Acquisition of French, German and Asia Pacific Operations of Small Bone Innovations 118
Novadaq Completes Acquisition Of Aimago 120
Stryker Completes Acquisition Of Berchtold For US$172 Million 122
Stryker Completes Acquisition Of Patient Safety Technologies For US$120 Million 123
Stryker Completes Acquisition Of Pivot Medical, Orthopedic Device Company 125
Physio-Control Acquires Sansio 127
Stryker Completes Acquisition Of Mako Surgical For US$1.6 Billion 128
Stryker Completes Acquisition of Trauson Holdings, Orthopaedic Products Manufacturer, For US$764 Million 130
Stryker Completes Acquisition Of Surpass Medical, Neurological Devices Maker, For Up To US$135 Million 132
Stryker Corp – Key Competitors 133
Stryker Corp – Key Employees 134
Stryker Corp – Locations And Subsidiaries 135
Head Office 135
Other Locations & Subsidiaries 135
Business Unit 142
Recent Developments 143
Financial Announcements 143
Jul 24, 2018: Stryker reports second quarter 2018 operating results 143
Apr 26, 2018: Stryker reports first quarter 2018 operating results 144
Jan 30, 2018: Stryker reports 2017 results and 2018 outlook 145
Jan 09, 2018: Stryker provides 2017 preliminary net sales results 147
Oct 26, 2017: Stryker reports third quarter 2017 results 148
Jul 27, 2017: Stryker reports second quarter 2017 results 150
Apr 25, 2017: Stryker reports first quarter 2017 results 151
Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 152
Jan 10, 2017: Stryker provides 2016 preliminary net sales results 154
Corporate Communications 156
Jul 10, 2018: Stryker announces organizational changes 156
Apr 03, 2018: Stryker announces organizational changes: Lonny J. Carpenter to retire 157
Jan 08, 2018: Stryker announces nomination of two new Directors, Sheri S. McCoy and Rajeev Suri 158
Dec 12, 2017: Stryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors 159
Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd 160
Legal and Regulatory 161
Sep 28, 2018: SEC charges Stryker a second time for FCPA violations 161
Aug 16, 2018: KFx Medical sues Stryker for Patent Infringement 162
Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker 163
Product News 164
Apr 18, 2018: Stryker to showcase its groundbreaking Target Guided Surgery navigation system at the Combined Otolaryngology Spring Meetings 164
Mar 07, 2018: Stryker unveils markets first reusable suture passer for arthroscopic rotator cuff repair, Cobra 165
Oct 30, 2017: Just-in-time 3D implants set to transform tumour surgery 166
Aug 23, 2017: Stryker provides an update regarding Sage warning letter and revised financial guidance 168
Other Significant Developments 169
Oct 30, 2017: Strykers Performance Solutions Launches Practice Excellence Program to Help Physician Practices Drive Profitability, Efficiency & Quality Outcomes 169
Appendix 170
Methodology 170
About GlobalData 170
Contact Us 170
Disclaimer 170

List of Tables
Stryker Corp, Medical Equipment, Key Facts, 2017 2
Stryker Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Stryker Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Stryker Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Stryker Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Stryker Corp, Deals By Market, 2012 to YTD 2018 11
Stryker Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Entellus Medical Acquires XeroGel Assets from CogENT Therapeutics for USD11 Million 16
Stryker Acquires Vertebral Augmentation Solutions Business from Becton, Dickinson 17
Stryker Acquires Minimally-Invasive Spine Surgery Portfolio from SafeWire 18
Stryker Acquires Neuro Portfolio Assets of Synergetics 19
Stryker Acquires Assets of CHG Hospital Beds 20
Stryker Acquires ENT Surgery Business Unit from Polyganics 21
Novadaq to Acquire Rights to SPY Elite System from LifeCell 22
Patient Safety Technologies To Acquire Patents From ClearCount Medical Solutions 23
Mako Surgical Completes Acquisition Of Orthopedic Assets Of Pipeline Biomedical 24
Novadaq Technologies Acquires Surgical Marker Technology From TauTona 25
Novadaq Technologies Acquires Surgical Imaging Technology Assets From Digirad For USD3 Million 26
Stryker Acquires Spinal Implant Technologies From VertiFlex 28
Spirox Raises USD18.5 Million in Series B Financing 29
Stanmore Implants Raises US$12.3 Million In Venture Financing Round 30
Nasoform Raises US$5.3 Million In Venture Financing 31
Spirox Raises USD45 Million in Series C Financing 32
Madison Dearborn Partners Completes Acquisition Of Sage Products, Maker Of Disposable Healthcare Products 34
Bain Capital Completes Acquisition Of Physio-Control From Medtronic For US$487 Million 36
LaunchPad Medical Enters into Licensing Agreement with Stryker 38
Stryker Enters into Partnership with Ziehm Imaging 39
Synaptive Medical Enters into Partnership with Stryker 40
3D Systems Enters into Distribution Agreement with Stryker 41
Stryker and AlloSource Enter into Distribution Partnership 42
EOS imaging Enters into Co-Promotion Agreement with Stryker 43
Entellus Medical Enters into Co-Marketing Agreement with Xoran Technologies 44
Ziehm Imaging Enters into Co-Marketing Agreement with Stryker 45
Novadaq Technologies Enters into Co-Marketing Agreement with Arthrex 46
Entellus Medical Expands Distribution Agreement with Fiagon 47
Physio-Control Enters into Distribution Agreement with Aircraft Medical 48
Osiris Therapeutics Enters into Agreement with Stryker for Viable Bone Matrix 49
Novadaq Technologies Enters into Distribution Agreement with LifeNet Health for DermACELL Tissue Products 50
Novadaq Enters into Distribution Agreement with Kirloskar 51
Stryker Enters Into Agreement With NeuroLogica For BodyTom CT Scanner 52
Novadaq Enters Into Distribution Agreement With Swissray Asia 53
IMRIS Enters Into Technology Integration Agreement With Stryker 54
Entellus Medical Enters Into Distribution Agreement With CogENT Therapeutics For XeroGel 55
Stryker Extends Co-Marketing Agreement With OrthoSensor 56
NeuroLogica Enters Into Co-Development Agreement With Stryker 57
Novadaq Technologies Enters Into Distribution Agreement With MAQUET Cardiovascular 58
Ember Therapeutics Receives BMP-7 and OP-1 Portfolio from Stryker 59
Entellus Medical Plans to Raise up to USD172.3 Million in Public Offering of Shares 60
Entellus Medical Raises USD50 Million in Private Placement of Shares 61
Entellus Medical Raises USD60 Million in Public Offering of Shares 62
Entellus Medical Raises USD90 Million in IPO 64
Novadaq Technologies Completes Public Offering Of Shares For US$104.7 Million 66
Novadaq Completes Public Offering Of Common Stock For US$58 Million 68
Mako Surgical Completes Public Offering Of Common Stock For US$46 Million 70
Patient Safety Technologies Completes Private Placement Of Shares For US$3.5 Million 71
Novadaq Technologies Completes Public Offering Of Common Shares For US$40 Million 72
Stryker Raises USD600 Million in Public Offering of 3.65% Notes Due 2028 74
Stryker Prices Public Offering of 1.800% Notes Due 2019 for USD500 Million 76
Stryker Raises USD1 Billion in Public Offering of 3.5% Notes Due 2026 77
Stryker Raises USD750 Million in Public Offering of 2% Notes Due 2019 79
Stryker Raises USD750 Million in Public Offering of 2.625% Notes Due 2021 81
Stryker Raises USD1 Billion in Public Offering of 4.625% Notes Due 2046 83
Stryker Raises USD750 Million in Public Offering of 3.375% Notes Due 2025 85
Physio-Control Plans to Raise USD150 Million in Public Offering of Debt 87
Stryker Completes Public Offering Of Notes Due 2024 For US$600 Million 88
Stryker Completes Public Offering Of Notes Due 2044 For US$400 Million 90
Stryker Completes Public Offering Of Notes Due 2018 For US$600 Million 92
Stryker Completes Public Offering Of Notes Due 2043 For US$400 Million 94
Stryker Acquires HyperBranch Medical 96
Stryker to Acquire Invuity for USD190 Million 98
Stryker to Acquire K2M Group 100
Stryker to Acquire SafeAir 102
Stryker Acquires Entellus Medical for USD662 Million 103
Stryker to Acquire Vexim 105
Stryker Acquires Novadaq Technologies for USD701 Million 107
Entellus Medical Acquires Spirox from KKR Fund for USD81 Million 109
Stryker to Acquire Instratek 110
Stryker Acquires Stanmore Implants from SIW Holdings for USD52 Million 111
Stryker Acquires Physio-Control for USD1.299 Billion 112
Stryker Acquires Sage Products from Madison Dearborn Partners for USD2.9 Billion 114
Physio-Control to Acquire HeartSine Technologies 116
Stryker Acquires Muka Metal 117
Stryker Completes Acquisition of French, German and Asia Pacific Operations of Small Bone Innovations 118
Novadaq Completes Acquisition Of Aimago 120
Stryker Completes Acquisition Of Berchtold For US$172 Million 122
Stryker Completes Acquisition Of Patient Safety Technologies For US$120 Million 123
Stryker Completes Acquisition Of Pivot Medical, Orthopedic Device Company 125
Physio-Control Acquires Sansio 127
Stryker Completes Acquisition Of Mako Surgical For US$1.6 Billion 128
Stryker Completes Acquisition of Trauson Holdings, Orthopaedic Products Manufacturer, For US$764 Million 130
Stryker Completes Acquisition Of Surpass Medical, Neurological Devices Maker, For Up To US$135 Million 132
Stryker Corp, Key Competitors 133
Stryker Corp, Key Employees 134
Stryker Corp, Other Locations 135
Stryker Corp, Subsidiaries 136
Stryker Corp, Business Unit 142

List of Figures
Stryker Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Stryker Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Stryker Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Stryker Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Stryker Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Stryker Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 9
Stryker Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Stryker Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 11

★海外企業調査レポート[Stryker Corp (SYK):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ignyta Inc (RXDX)-製薬・医療分野:企業M&A・提携分析
    Summary Ignyta Inc (Ignyta), formerly NexDx Inc is a drug manufacturing company that discovers, develops and commercializes new drugs targeting activated genes in cancer cells for the treatment of cancer patients. The company develops products using integrated therapeutic (Rx) and companion diagnost …
  • Panhandle Oil and Gas Inc (PHX):石油・ガス:M&Aディール及び事業提携情報
    Summary Panhandle Oil and Gas Inc (Panhandle) sells oil, natural gas liquid (NGL) and natural gas produced from non-operated assets through working interests, royalty interests and both in producing oil and natural gas wells and those in the process of being drilled or completed. The company operate …
  • Seikagaku Corp (4548):企業の財務・戦略的SWOT分析
    Summary Seikagaku Corp (Seikagaku) is a manufacturer and supplier of pharmaceuticals and medical devices. The company offers products such as pharmaceuticals and medical devices, bulk products, endotoxin-detecting reagents and oral care products. It manufactures and markets pharmaceutical products c …
  • VWR International LLC:医療機器:M&Aディール及び事業提携情報
    Summary VWR International LLC (VWR), a subsidiary of Avantor Performance Materials Inc, is a provider of product and service solutions to laboratory and production companies. The company offers products such as adhesive dispensers, adhesive labels, adhesive slides, agarose and acrylamide, air freshe …
  • Heinzel Holding GmbH:企業の戦略的SWOT分析
    Heinzel Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Power Financial Corporation:企業の戦略・SWOT・財務情報
    Power Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Power Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Douglas Holding AG:戦略・SWOT・企業財務分析
    Douglas Holding AG - Strategy, SWOT and Corporate Finance Report Summary Douglas Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Duke Energy Corporation (DUK)-エネルギー分野:企業M&A・提携分析
    Summary Duke Energy Corporation (Duke Energy) is an integrated energy utility that undertakes the generation, transmission, distribution and sale of electricity; transportation and sale of natural gas; and provision of related energy services in the Southeast and Midwest regions of the US. It also p …
  • Pioneer Natural Resources Co Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Pioneer Natural Resources Co Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Pioneer Natural Resources Co (Pioneer) is an independent oil and natural gas exploration and production company. Its principally operates in Eagle Ford Shale, Permian Basin, Raton Basin, …
  • Park Hotels & Resorts Inc (PK):企業の財務・戦略的SWOT分析
    Park Hotels & Resorts Inc (PK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Airbus SE (AIR):企業の財務・戦略的SWOT分析
    Airbus SE (AIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Tokyo Broadcasting System Holdings Inc (9401):企業の財務・戦略的SWOT分析
    Tokyo Broadcasting System Holdings Inc (9401) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Mikros Systems Corporation:企業の戦略・SWOT・財務分析
    Mikros Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary Mikros Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Teco Energy Inc:企業の戦略的SWOT分析
    Teco Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Chang Chun Petrochemical Co Ltd:企業の戦略的SWOT分析
    Chang Chun Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Lee’s Pharmaceutical Holdings Ltd (950):企業の財務・戦略的SWOT分析
    Summary Lee's Pharmaceutical Holdings Ltd (Lee's Pharmaceutical) is a bio pharmaceutical company that offers development of novel therapies and contract research services. The company provides products in the treatment of disease areas such as urology, cardiovascular oncology, dermatology, hematolog …
  • Jardine Cycle & Carriage Ltd (C07):企業の財務・戦略的SWOT分析
    Jardine Cycle & Carriage Ltd (C07) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • China Galaxy Securities Co., Ltd. (6881):企業の財務・戦略的SWOT分析
    China Galaxy Securities Co., Ltd. (6881) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Ascletis Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ascletis Inc (Ascletis) is a healthcare company that provides therapeutics for cancer and infectious diseases. The company offers discovery, demonstration of global partnering, clinical proof-of-concept, and research and development services of novel therapeutics for life-threatening disease …
  • Eastern Platinum Limited:企業の戦略・SWOT・財務情報
    Eastern Platinum Limited - Strategy, SWOT and Corporate Finance Report Summary Eastern Platinum Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆